106 related articles for article (PubMed ID: 10427875)
21. Cervical cancer screening coverage in a high-incidence region.
Navarro C; Fonseca AJ; Sibajev A; Souza CI; Araújo DS; Teles DA; Carvalho SG; Cavalcante KW; Rabelo WL
Rev Saude Publica; 2015; 49():17. PubMed ID: 25741655
[TBL] [Abstract][Full Text] [Related]
22. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening beliefs among young Hispanic women.
Byrd TL; Peterson SK; Chavez R; Heckert A
Prev Med; 2004 Feb; 38(2):192-7. PubMed ID: 14715211
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
25. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
26. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.
Dzuba IG; Díaz EY; Allen B; Leonard YF; Lazcano Ponce EC; Shah KV; Bishai D; Lorincz A; Ferris D; Turnbull B; Hernández Avila M; Salmerón J
J Womens Health Gend Based Med; 2002 Apr; 11(3):265-75. PubMed ID: 11988136
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening among Lebanese women.
Bou-Orm IR; Sakr RE; Adib SM
Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
[TBL] [Abstract][Full Text] [Related]
28. Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence.
Martín-López R; Hernández-Barrera V; de Andres AL; Carrasco-Garrido P; de Miguel AG; Jimenez-Garcia R
Eur J Cancer Prev; 2012 Jan; 21(1):82-8. PubMed ID: 22129658
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with underscreening for cervical cancer among women in Canada.
Schoueri-Mychasiw N; McDonald PW
Asian Pac J Cancer Prev; 2013; 14(11):6445-50. PubMed ID: 24377548
[TBL] [Abstract][Full Text] [Related]
30. [The coverage of cervical screening in Hungary].
Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
[TBL] [Abstract][Full Text] [Related]
31. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study.
Flores Y; Bishai D; Lazcano E; Shah K; Lörincz A; Hernández M; Salmerón J
Salud Publica Mex; 2003; 45 Suppl 3():S388-98. PubMed ID: 14746032
[TBL] [Abstract][Full Text] [Related]
32. Knowledge about cervical cancer prevention and psychosocial barriers to screening among Mexican women.
Marván ML; Ehrenzweig Y; Catillo-López RL
J Psychosom Obstet Gynaecol; 2013 Dec; 34(4):163-9. PubMed ID: 24156635
[TBL] [Abstract][Full Text] [Related]
33. Cervix cancer screening in Croatia within the European Cervical Cancer Prevention Week.
Skopljanac-Macina L; Mahovlić V; Ovanin-Rakić A; Barisić A; Rajhvajn S; Juric D; Babić D; Corusić A; Oresković S
Coll Antropol; 2010 Jun; 34(2):613-7. PubMed ID: 20698138
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
35. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
36. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
37. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain).
Borràs JM; Guillen M; Sánchez V; Juncà S; Vicente R
Eur J Cancer Prev; 1999 Oct; 8(5):427-34. PubMed ID: 10548398
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with cervical cancer screening amongst women of reproductive age from Yucatan, Mexico.
Conde-Ferraez L; Suarez Allen RE; Carrillo Martinez JR; Ayora-Talavera G; Gonzalez-Losa Mdel R
Asian Pac J Cancer Prev; 2012; 13(9):4719-24. PubMed ID: 23167409
[TBL] [Abstract][Full Text] [Related]
39. Cervical screening uptake and its predictors among rural women in Malaysia.
Gan DE; Dahlui M
Singapore Med J; 2013 Mar; 54(3):163-8. PubMed ID: 23546031
[TBL] [Abstract][Full Text] [Related]
40. Coverage and focus of a cervical cancer prevention program in southern Brazil.
de Quadros CA; Victora CG; da Costa JS
Rev Panam Salud Publica; 2004 Oct; 16(4):223-32. PubMed ID: 15615596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
